Tuesday, June 16

Posters
Learn more.

Resolving Wicked Problems with High-Reliability Leadership
Planned in cooperation with the ASHP Foundation Center for Health-System Pharmacy Leadership
Leading the Pharmacy Enterprise in Challenging Times Learning Community
ACPE Program #204-000-09-112-L04P
2.0 Contact Hours / Application-based
Moderator:  Sharon M. Enright, RPh, MBA, President, Envision Change, Richmond, VA

Wicked problems can’t be solved, but they can be managed.  They are not just difficult, but different because they can’t be solved with traditional solutions.  But as John Foster Dulles reminded us, “The measure of success is not whether you have a tough problem to deal with, but whether it is the same problem you had last year.” 

High-reliability organizations (HROs) function in high consequence enterprises—like pharmacy’s medication use system.  Yet somehow, HROs have fewer than their fair share of accidents.  Risk is a function of consequence and probability.  By decreasing the probability of an accident, HROs recast a high-risk enterprise as merely a high-consequence enterprise.  What does it take to achieve high-reliability performance?  Creating a robust culture of safety and the conditions necessary achieve high reliability performance are critical, and a key element is a defined leadership method.  HROs understand the science of human performance and event prevention and integrate this knowledge into how they design and manage their systems.

We need a new way of thinking, a new culture, a new set of skills, and a realization that we will have to behave differently.  This session reviews foundational concepts of human performance in complex systems, describes characteristics of HROs, and provides insights into high-leverage leadership tactics that can be applied by all leaders, regardless of title, in optimizing reliability in medication safety.  

Learning Objectives:

• Describe core principles of human performance in complex systems, and apply these concepts to improve performance reliability in medication practices.
• Describe the characteristics of high-reliability organizations (HROs) and the importance of a strong leadership culture.
• Define and apply high-leverage strategies and tactics for high-reliability leadership, specifically related to ensuring medication safety.

8:00 a.m. – 8:15 a.m.
Announcements

8:15 a.m. – 9:30 a.m.
Resolving Wicked Problems with High-Reliability Leadership
Carole A. Stockmeier, MHA, CMQ/OE, Practice Director, Healthcare Performance Improvement, Norfolk, VA
Dan Degnan, PharmD, MS, Medication Safety Officer and Interim Vice President of Pharmacy, Community Health Network, Indianapolis, IN

9:30 a.m. – 10:00 a.m.
Panel and Audience Dialogue
Carole A. Stockmeier
Steven R. Abel, BS, PharmD, FASHP, Assistant Dean for Clinical Programs; and Bucke Professor and Head, Department of Pharmacy Practice, Purdue University, Indianapolis, IN
Sara J. White, MS, FASHP, Pharmacy Leadership Coach, Mountain View, CA

Clinical Update for Managers
Planned in cooperation with the ASHP Quality Improvement Initiative
Quality Standards in Clinical Practice Series
ACPE Program #204-000-09-113-L01P
2.0 Contact Hours / Application-based
Moderator:  Kevin W. Garey, PharmD, MS, Associate Professor and Chair, University of Houston College of Pharmacy, Houston, TX

Has being in management taken you away from the front lines?  Feeling out of touch?  This session will help bridge the gap.  Get the latest clinical pearls most important for managers. 

Learning Objectives:

• Describe current key clinical issues impacting pharmacy.
• Define challenges and solutions in the current clinical arena.
• Determine clinical applications appropriate to your setting.

8:00 a.m. – 8:05 a.m.
Announcements

8:05 a.m. – 9:00 a.m.
Clinical Update in Emergency Medicine

8:05 a.m. – 8:30 a.m.
State of the Art Mini-Review: Emergency Medicine
George Delgado, Jr., PharmD, Coordinator Emergency Pharmacy Services, Detroit Receiving Hospital, Detroit, MI

8:30 a.m. – 8:50 a.m.
Implementing an Emergency Medicine Pharmacy Service
Joyce A. Tipton, RPh, MBA, Chief Pharmacy Officer, Baylor Clinic and Hospital, Houston, TX

8:50 a.m. – 9:00 a.m.
Questions, Answers, and Discussion

9:00 a.m. – 10:00 a.m.
Clinical Update in Drug Safety Monitoring

9:00 a.m. – 9:30 a.m.
State of the Art Mini-Review: Drug Safety and Clinical Pharmacy
Milap C. Nahata, PharmD, MS, FASHP, Chairman and Professor, Pharmacy, Pediatrics and Internal Medicine, The Ohio State University - College of Pharmacy, Columbus; and Associate Director of Pharmacy, The Ohio State University Medical Center, Columbus

9:30 a.m. – 9:50 a.m.
Protocols to Improve Drug Safety Monitoring
Vikas Gupta, PharmD, BCPS, Director, Cardinal Health, Birmingham, AL

9:50 a.m. – 10:00 a.m.
Questions, Answers, and Discussion

Telepharmacy: Innovative Methods and Increasing Access to Clinical Pharmacy
Informatics Series
ACPE Program #204-000-09-114-L04P / 204-000-09-114-L04T
2.0 Contact Hours / Application-based
Moderator:  Brent I. Fox, PharmD, PhD, Assistant Professor, Auburn University Harrison School of Pharmacy, Auburn, AL

Have you explored the possibilities of using information technology to expand and increase access to the clinical services of pharmacists and as a time and cost-saving measure?  Telepharmacy has been shown to be successful in supporting medication use over distances large and small.  Learn how telepharmacy supports a variety of innovative pharmacy activities, including ICU needs, order entry and review, and specialty clinics.

Learning Objectives:

• Describe examples of successful and innovative uses of telepharmacy to support medication management to increase access to pharmacy services.
• Explain anticipated cost and time savings that can be achieved through uses of telepharmacy.
• Identify ways that telepharmacy may be effectively used in your institution.
• Describe regulatory and organizational barriers to telepharmacy.

8:00 a.m. – 8:05 a.m.
Announcements

8:05 a.m. – 8:50 a.m.
From Conception to the Present: Telepharmacy at Oregon Health and Science University
Michael J. Brownlee, PharmD, MS, Assistant Director, Oregon Health & Science University, Portland

8:50 a.m. – 9:35 a.m.
Telepharmacy at Aurora Health: Meeting a Defined Critical Care Need
Tom Woller, MS, FASHP, Vice President, Pharmacy Services, Aurora Health Care, Milwaukee, WI

9:35 a.m. – 9:50 a.m.
Small Group Discussion: Telepharmacy Challenges, Successes, and Plans

9:50 a.m. – 10:00 a.m.
Questions, Answers, and Discussion

Shrink Your ADE Hospital Admissions
ASHP Research and Education Foundation Award for Excellence in Medication-Use Safety Winner
Hot Topic
ACPE Program #204-000-09-115-L05P
2.0 Contact Hours / Knowledge-based
Moderator:  Cynthia L. LaCivita, PharmD, Director of Education and Special Programs, ASHP Research and Education Foundation, Bethesda, MD

Find out how Novant Medical Group of Winston-Salem, North Carolina, created a remarkable 29% reduction in all-cause hospital admissions and reduced adverse drug event admissions to less than 5% of all hospital admissions.  This session will describe the successful process that achieved these results, which you can replicate in your setting to improve safety and reduce costs.

Learning Objectives:

• Describe the process used at Novant Medical Group for reducing hospital admissions due to adverse drug events.
• Identify three patient specific and three disease specific risk factors for adverse drug events.
• Identify three ways that you can apply this process in your setting.
• Identify effective methods for decreasing adverse drug events in all populations.

8:00 a.m. – 8:05 a.m.
Announcements

8:05 a.m. – 9:00 a.m.
Bridging the Gap
Terri B. Cardwell, BS Pharm, PharmD, Safe Med Team Leader, Novant Health, Winston-Salem, NC

9:00 a.m. – 9:05 a.m. 
Questions, Answers, and Discussion

9:05 a.m. – 9:55 a.m. 
The Patient Experience
Jennifer M. Rief, PharmD, Safe Med Clinical Pharmacist, Novant Health, Charlotte, NC

9:55 a.m. – 10:00 a.m.
Questions, Answers, and Discussion

Are You Ready?  Emergency Management Planning in Today's World
Hot Topic
ACPE Program #204-000-09-116-L04P
2.0 Contact Hours / Knowledge-based
Moderator:  Mary Andrawis, PharmD, MPH, Medication-Use Quality Improvement Associate, American Society of Health-System Pharmacists, Bethesda, MD

Would you be ready if a hurricane hits your hospital?  How about an extended power outage?  Terrorist attack?  Hear from pharmacists who have experienced emergencies and managed them successfully.  How did they do it?  What do they recommend you do to be ready?  Leave this session knowing what to do next so you can be prepared for the unthinkable.

Learning Objectives:

• Identify the essential elements of a comprehensive program of pharmacy emergency management.
• Write a continuity plan for one key pharmacy department process.
• Discuss one training exercise to prepare staff to respond to an emergency or disaster.
• Describe how the plans of the pharmacy department, healthcare institution, the local health department, and the community can be integrated.

8:00 a.m. – 8:05 a.m.
Announcements

8:05 a.m. – 8:15 a.m.
Introduction to Emergency Management Planning
Mary Andrawis

8:15 a.m. – 8:45 a.m.
Emergency Management Planning from a National Perspective
Erin Mullen, RPh, PhD, Assistant Vice President, Rx Response, Pharmaceutical Research and Manufacturers of America, Washington, DC

8:45 a.m. – 9:15 a.m.
Emergency Management Planning from a State Perspective
Michael J. Robbins, PharmD, Pharmacist, Chicago Department of Public Health, Chicago, IL

9:15 a.m. – 9:45 a.m.
Emergency Management Planning from an Institutional Perspective
Joanne C. Witsil, PharmD, RN, Clinical Pharmacist, Emergency Medicine/Toxicology, John H. Stroger Jr. Hospital of Cook County, Chicago, IL

9:45 a.m. – 10:00 a.m.
Questions, Answers, and Discussion

The Inaugural and Awards

Welcoming Remarks: ASHP President Kevin J. Colgan, MA, RPh, FASHP, Senior Vice President of Health Economics and Outcomes Research, EPI-Q, Inc., Oakbrook, IL

2009 ASHP Practitioner Recognition Awards Presentation

ASHP Board of Directors Awards Presentation:

Honorary Membership:  Fela Viso-Gurovich, PhD, Faculty, University of The State of Hidalgo, Pachuca, Hidalgo, Mexico

Award of Excellence:  Christopher A. Hatwig, MS, RPh, FASHP, Vice President, Apexus/340B Prime Vendor Program, Irving, TX

Incoming ASHP President Inaugural Address:  Lynnae M. Mahaney, MBA, FASHP, Chief, Pharmacy Services, William S. Middleton Memorial Veterans Hospital, Madison, WI
Learn more.

House of Delegates Caucuses Facilitated by the Chair of the House

Exhibit Program and Lunch in the Exhibit Hall
Learn more.

Meet the Experts
Consult with big names in pharmacy.  Head for the Exhibit Hall, where pharmacy experts are stationed at tables, each labeled with their area of expertise.  Choose an expert in an area important to you and ask your burning questions.
Learn more.

Poster Presentations
Learn more.

The Economic Stimulus Package:  A Catalyst for Healthcare Reform
Hot Topic
ACPE Program #204-000-09-120-L03P
2.5 Contact Hours / Knowledge-based
Moderator:  Kasey K. Thompson, PharmD, Assistant Director, Office of Policy, Planning and Communications, American Society of Health-System Pharmacists, Bethesda, MD

Find out the latest legislative and regulatory issues affecting hospital and health-system pharmacy.  Learn about issues being considered by Congress, the Centers for Medicare and Medicaid Services, the Food and Drug Administration, and state legislators and regulators.  Apply this information to a range of practice topics and settings.

Learning Objectives:

• Identify current regulatory and legislative issues impacting health-system pharmacists in a variety of practice settings.
• Explain how the regulatory and legislative information applies to a range of practice topics.

2:00 p.m. – 2:05 p.m.
Announcements

2:05 p.m. – 2:20 p.m.
The Political Landscape in 2009:  Challenges and Opportunities for Health-System Pharmacy
Brian M. Meyer, BA, MBA, Director, Government Affairs Division, American Society of Health-System Pharmacists, Bethesda, MD

2:20 p.m. – 2:40 p.m.
The 111th Congress:  Can It Pass Health Care Reform and Recognize Pharmacists as Providers?
Joseph M. Hill, MA, Director, Federal Legislative Affairs, American Society of Health-System Pharmacists, Bethesda, MD

2:40 p.m. – 3:00 p.m.
The Obama Administration Beyond Healthcare Reform:  The Rest of the Agenda at Health and Human Services
Justine K. Coffey, JD, LLM, Director, Federal Regulatory Affairs, American Society of Health-System Pharmacists, Bethesda, MD

3:00 p.m. – 3:20 p.m.
Creative Laboratories for Change:  Improving Health Care One State at a Time
Geralyn Trujillo, MPP, Director, State Government Affairs, American Society of Health-System Pharmacists, Bethesda, MD

3:20 p.m. – 3:40 p.m.
Understanding the HITECH Act:  Health Information Technology Provision in the Stimulus Package
Kevin C. Marvin, MS, FASHP, FHIMSS, Principal, Kevin Marvin Consulting LLC, Burlington, VT

3:40 p.m. – 4:00 p.m.
Grassroots Advocacy:  Bringing it Home to Your Practice Site
Brian M. Meyer

4:00 p.m. – 4:30 p.m.
Questions, Answers, and Discussion

Applying Skills to Resolve Wicked Problems
Planned in cooperation with the ASHP Foundation Center for Health-System Pharmacy Leadership
Leading the Pharmacy Enterprise in Challenging Times Learning Community
ACPE Program #204-000-09-117-L04P
2.5 Contact Hours / Application-based
Moderator:  Sharon M. Enright, RPh, MBA, President, Envision Change, Richmond, VA

This highly interactive workshop session will offer facilitated breakout discussions for affinity groups addressing critical characteristics of high-reliability organizations and explore the use of tools and resources presented during the two presentation sessions.  Discussions will focus on application of the tools, techniques, and strategies to the wicked problems of medication safety and the larger challenges facing healthcare organizations in the current turbulent climate of change and fiscal pressure.  Participants will use exercises and cases to establish preliminary plans for exporting these concepts into their daily practice.

Learning Objectives:

• Develop a personal action plan for recognizing and applying leadership strategies and tactics, and critical thinking skills needed in complex environments.
• Apply critical thinking and change management skills to contemporary “wicked messes” resulting from the prevailing healthcare financial environment.
• Evaluate the potential impact of critical practice issues and organizational culture within your organization, and apply leadership principles to develop organizational strategies for success.

2:00 p.m. – 2:20 p.m.
Announcements and Introduction to Breakout Groups

2:20 p.m. – 2:30 p.m.
Move into Breakout Groups

2:30 p.m. – 4:15 p.m.
Breakout Sessions by Type/Size of Institutional Setting
Steven R. Abel, BS, PharmD, FASHP, Assistant Dean for Clinical Programs; and Bucke Professor and Head, Department of Pharmacy Practice, Purdue University, Indianapolis, IN
James A. Jorgenson, RPh, MS, FASHP, Executive Director of Pharmacy, Clarian Health Partners, Indianapolis, IN

Despina Kotis, PharmD, Northwestern Memorial Hospital, Chicago, IL
Sara J. White, MS, FASHP, Pharmacy Leadership Coach, Mountain View, CA

4:15 p.m. – 4:20 p.m.
Reconvene to Session

4:20 p.m. – 4:30 p.m.
Wrap Up and Introduction to Wednesday’s Session

Surely, You CHEST: Implementing American College of Chest Physicians' 2008 Guidelines for Antithrombotic and Thrombolytic Therapy
Planned in cooperation with the ASHP Quality Improvement Initiative
Quality Standards in Clinical Practice Series
ACPE Program #204-000-09-118-L01P
2.5 Contact Hours / Application-based
Moderator:  Ann K. Wittkowsky, PharmD, FCCP, FASHP Clinical Professor, University of Washington School of Pharmacy, Seattle; and Director, Anticoagulation Services, University of Washington Medical Center, Seattle

Find out what you need to know about the recent changes to the American College of Chest Physicians’ (ACCP) Guidelines for Antithrombotic and Thrombolytic Therapy.  Learn how to apply the guidelines in your institution.

Learning Objectives:

• Describe recent changes to the American College of Chest Physicians’ Guidelines for Antithrombotic and Thrombolytic Therapy.
• Summarize implications of the guideline changes for your institution.
• Identify ways to implement guideline changes in your practice.
• Discuss the overlap of guideline changes with National Patient Safety Goals and venous thromboembolism performance measures.

2:00 p.m. – 2:05 p.m.
Announcements

2:05 p.m. – 2:25 p.m.
The ACCP Guidelines: Grades of Recommendation, Development Methodology, and Application to Patient Care
Ann K. Wittkowsky

2:25 p.m. – 2:55 p.m.
New Guidelines for VTE Prophylaxis
Edith Nutescu, PharmD, FCCP, Clinical Associate Professor; and Director, Antithrombosis Center, University of Illinois at Chicago, Chicago

2:55 p.m. – 3:25 p.m.
New Guidelines for VTE Treatment
Ann K. Wittkowsky

3:25 p.m. – 4:00 p.m.
New Guidelines for Special Populations
Edith Nutescu

4:00 p.m. – 4:15 p.m.
New Guidelines for Bridge Therapy
Ann K. Wittkowsky

4:15 p.m. – 4:30 p.m.
Questions, Answers, and Discussion

Optimizing Medication Reconciliation with ePrescribing (E-Rx)
Informatics Series
ACPE Program #204-000-09-119-L04P / 204-000-09-119-L04T
2.5 Contact Hours / Application-based
Moderator:  Brent I. Fox, PharmD, PhD, Assistant Professor, Auburn University Harrison School of Pharmacy, Auburn, AL

Institutions are faced with medication reconciliation requirements.  Pharmacy is a key stakeholder and is currently using both paper and electronic methods to document this process.  Software applications have been implemented to address the medication reconciliation requirement.  At the same time, electronic prescribing for outpatients continues to gain momentum.  Come to this session to hear from your colleagues who have successfully addressed medication reconciliation using electronic tools.  Get the scoop on electronic prescribing including a regulatory and vendor update, and how it can positively impact the overall medication reconciliation process.  Learn how this can help justify the pharmacist role in these financially challenging times.

Learning Objectives:

• Describe benefits and limitations of electronic tools designed to facilitate medication reconciliation.
• Summarize the current status of electronic prescribing including usage trends, regulatory issues, the vendor marketplace, and physician incentives.
• Describe the importance of electronic prescribing and implementation methods for institutional healthcare facilities.
• Compare and contrast ways that electronic prescribing information can be integrated into the medication reconciliation process.

2:00 p.m. – 2:05 p.m.
Announcements

2:05 p.m. – 2:45 p.m.
Current State of ePrescribing and the Link to eMedication Reconciliation
Ken Majkowski, BS, PharmD, VP Clinical Affairs and Product Strategy, SureScripts-RxHub LLC, Saint Paul, MN

2:45 p.m. – 3:30 p.m.
Moving Medication Reconciliation from Paper to Electronic: Lessons Learned
Joan S. Kramer, PharmD, BCPS, Clinical Research and Hospital Medicine Specialist, Wesley Medical Center, Wichita, KS

3:30 p.m. – 4:15 p.m.
Utilizing an Electronic Medication History to Fully Implement Medication Reconciliation
Janice M. Dunsavage, RPh, MAS, Director of Pharmacy, Pinnacle Health System, Harrisburg, PA

4:15 p.m. – 4:30 p.m.
Questions, Answers, and Discussion

Effective Management of Pharmaceutical and Hazardous Waste
Hot Topic
ACPE Program #204-000-09-121-L04P
2.5 Contact Hours / Knowledge-based
Moderator:  Kathy Pflaum, BA, Inventory Control Coordinator, St. Francis Health Center, Topeka, KS

In this session, learn how the Resource Conservation and Recovery Act can guide your institution’s procedures for the disposal of pharmaceutical and hazardous waste.  Share the issues you face and find out how others are effectively managing this challenge.

Learning Objectives:

• Summarize issues and challenges in the disposal of pharmaceutical and hazardous waste in the pharmacy.
• Describe applications of the Resource Conservation and Recovery Act to the disposal of pharmaceutical and hazardous waste.
• Identify effective practices for management of pharmaceutical and hazardous waste that you can apply in your institution.

2:00 p.m. - 2:05 p.m.
Announcements

2:05 p.m. - 3:25 p.m.
Managing Pharmaceutical Hazardous Waste
Firouzan "Fred" Massoomi, PharmD, FASHP, Pharmacy Operations Coordinator, Nebraska Methodist Hospital, Omaha

3:25 p.m. - 3:40 p.m.
Questions, Answers, and Discussion

3:40 p.m. - 3:50 p.m.
Case in Action
Kathy Pflaum

3:50 p.m. - 4:10 p.m.
Small Group Action Plan Development
Kathy Pflaum
Firouzan "Fred" Massoomi

4:10 p.m. - 4:30 p.m.
General Discussion by Group of Action Plans
Kathy Pflaum
Firouzan "Fred" Massoomi

House of Delegates Second Meeting

Harvey A.K. Whitney Lecture Award Reception and Dinner
Tickets required.  Learn more.